Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
103.50
+2.20 (2.17%)
Apr 6, 2026, 2:24 PM IDT

Novolog (Pharm-Up 1966) Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5226429257261,4091,504
Market Cap Growth
-35.76%-30.63%27.45%-48.50%-6.30%5.66%
Enterprise Value
5966419046741,4701,449
Last Close Price
1.021.261.761.322.522.65
PE Ratio
126.88155.9323.39-29.6635.53
Forward PE
-14.0214.0214.0214.0214.02
PS Ratio
0.290.360.460.440.931.20
PB Ratio
1.421.742.421.833.033.50
P/TBV Ratio
16.1119.8017.4710.3713.199.06
P/FCF Ratio
--6.374.4316.0728.51
P/OCF Ratio
--5.843.6310.6218.03
EV/Sales Ratio
0.330.360.450.410.981.15
EV/EBITDA Ratio
5.698.298.654.9814.4015.81
EV/EBIT Ratio
12.6614.0012.4312.5018.9020.87
EV/FCF Ratio
-32.29-6.234.1216.7727.46
Debt / Equity Ratio
0.500.500.520.540.460.39
Debt / EBITDA Ratio
1.771.771.531.361.741.55
Debt / FCF Ratio
--1.371.312.433.16
Net Debt / Equity Ratio
0.170.17-0.13-0.040.09-0.17
Net Debt / EBITDA Ratio
0.800.80-0.47-0.130.39-0.78
Net Debt / FCF Ratio
-3.33-3.33-0.34-0.110.46-1.36
Asset Turnover
0.700.700.690.630.640.56
Inventory Turnover
5.835.836.536.747.074.97
Quick Ratio
0.730.730.830.850.870.92
Current Ratio
0.930.930.960.960.981.03
Return on Equity (ROE)
1.20%1.20%10.54%-9.15%11.38%12.35%
Return on Assets (ROA)
1.10%1.10%1.56%1.29%2.06%1.94%
Return on Invested Capital (ROIC)
7.52%7.89%14.53%12.23%13.53%16.38%
Return on Capital Employed (ROCE)
8.50%8.50%12.60%8.90%11.40%11.60%
Earnings Yield
0.79%0.64%4.28%-5.79%3.37%2.81%
FCF Yield
-3.53%-2.88%15.69%22.57%6.22%3.51%
Dividend Yield
3.83%3.12%2.78%2.23%2.60%3.54%
Payout Ratio
486.03%486.03%101.17%-67.14%75.62%
Buyback Yield / Dilution
-0.02%-0.02%0.04%0.94%-0.14%-9.08%
Total Shareholder Return
3.81%3.09%2.82%3.17%2.46%-5.54%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.